Page 71 - Read Online
P. 71

Page 14 of 16                      Bookland et al. J Cancer Metastasis Treat 2019;5:33  I  http://dx.doi.org/10.20517/2394-4722.2018.110

               8.   Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta
                   Neuropathol 2012;123:465-72.
               9.   Dörner L, Fritsch MJ, Stark AM, Mehdorn HM. Posterior fossa tumors in children: how long does it take to establish the diagnosis?
                   Childs Nerv Syst 2007;23:887-90.
               10.  Andropoulos DB, Greene MF. Anesthesia and developing brains - implications of the FDA warning. N Engl J Med 2017;376:905-7.
               11.  Sheppard JP, Nguyen T, Alkhalid Y, Beckett JS, Salamon N, et al. Risk of brain tumor induction from pediatric head CT procedures: a
                   systematic literature review. Brain Tumor Res Treat 2018;6:1-7.
               12.  Bjur KA, Payne ET, Nemergut ME, Hu D, Flick RP. Anesthetic-related neurotoxicity and neuroimaging inchildren: a call for
                   conversation. J Child Neurol 2017;32:594-602.
               13.  Tomita T, McLone DG. Spontaneous seeding of medulloblastoma: results of cerebrospinal fluid cytology and arachnoid biopsy from the
                   cisterna magna. Neurosurgery 1983;12:265-7.
               14.  Al-Abbadi MA. Basics of cytology. Avicenna J Med 2011;1:18-28.
               15.  Gajjar A, Fouladi M, Walter AW, Thompson SJ, Reardon DA, et al. Comparison of lumbar and shunt cerebrospinal fluid specimens for
                   cytologic detection of leptomeningeal disease in pediatric patients with brain tumors. J Clin Oncol 1999;17:1825-8.
               16.  Zorofchian S, Iqbal F, Rao M, Aung PP, Esquenazi Y, et al. Circulating tumour DNA, microRNA and metabolites in cerebrospinal fluid as
                   biomarkers for central nervous system malignancies. J Clin Pathol 2019;72:271-280.
               17.  Shalaby T, Achini F, Grotzer MA. Targeting cerebrospinal fluid for discovery of brain cancer biomarkers. J Cancer Metastasis Treat
                   2016;2:176-87.
               18.  Kurman RJ, Scardino PT, McIntire KR, Waldmann TA, Javadpour N. Cellular localization of alpha-fetoprotein and human chorionic
                   gonadotropin in germ cell tumors of the testis using and indirect immunoperoxidase technique. Cancer 1977;40:2136-51.
               19.  Allen JC, Nisselbaum J, Epstein F, Rosen G, Schwartz MK. Alphafetoprotein and human chorionic gonadotropin determination in
                   cerebrospinal fluid. An aid to the diagnosis and management of intracranial germ-cell tumors. J Neurosurg 1979;51:368-74.
               20.  Qaddoumi I, Sane M, Li S, Kocak M, Pai-Panandiker A, et al. Diagnostic utility and correlation of tumor markers in the serum and
                   cerebrospinal fluid of children with intracranial germ cell tumors. Childs Nerv Syst 2012;28:1017-24.
               21.  Seregni E, Massimino M, Nerini Molteni S, Pallotti F, van der Hiel B, et al. Serum and cerebrospinal fluid human chorionic gonadotropin
                   (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors. Int J Biol Markers 2002;17:112-8.
               22.  Fukuoka K, Yanagisawa T, Suzuki T, Shirahata M, Adachi JI, et al. Human chorionic gonadotropin detection in cerebrospinal fluid of
                   patients with a germinoma and its prognostic significance: assessment by using a highly sensitive enzyme immunoassay. J Neurosurg
                   Pediatr 2016;18:573-7.
               23.  Allen J, Chacko J, Donahue B, Dhall G, Kretschmar C, et al. Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed
                   CNS germinoma. Pediatr Blood Cancer 2012;59:1180-2.
               24.  Seehusen DA, Reeves MM, Fomin DA. Cerebrospinal fluid analysis. Am Fam Physician 2003;68:1103-8.
               25.  Daneman R. The blood-brain barrier in health and disease. Ann Neurol 2012;72:648-72.
               26.  Peng M, Chen C, Hulbert A, Brock MV, Yu F. Non-blood circulating tumor DNA detection in cancer. Oncotarget 2017;8:69162-73.
               27.  Pentsova EI, Shah RH, Tang J, Boire A, You D, et al. Evaluating cancer of the central nervous system through next-generation sequencing
                   of cerebrospinal fluid. J Clin Oncol 2016;34:2404-15.
               28.  Ballester LY, Glitza Oliva IC, Douse DY, Chen MM, Lan C, et al. Evaluating circulating tumor DNA from the cerebrospinal fluid of
                   patients with melanoma and leptomeningeal disease. J Neuropathol Exp Neurol 2018;77:628-35.
               29.  Kennedy SR, Schmitt MW, Fox EJ, Kohrn BF, Salk JJ, et al. Detecting ultralow-frequency mutations by duplex sequencing. Nat Protoc
                   2014;9:2586-606.
               30.  Li Y, Pan W, Connolly ID, Reddy S, Nagpal S, et al. Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with
                   melanoma leptomeningeal brain metastases. J Neurooncol 2016;128:93-100.
               31.  Swinkels DW, de Kok JB, Hanselaar A, Lamers K, Boerman RH. Early detection of leptomeningeal metastasis by PCR examination of
                   tumor-derived K-ras DNA in cerebrospinal fluid. Clin Chem 2000;46:132-3.
               32.  Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas
                   and non-brainstem glioblastomas. Nat Genet 2012;44:251-3.
               33.  Wolff JE, Rytting ME, Vats TS, Zage PE, Ater JL, et al. Treatment of recurrent diffuse intrinsic pontine glioma: the MD anderson cancer
                   center experience. J Neurooncol 2012;106:391-7.
               34.  Huang TY, Piunti A, Lulla RR, Qi J, Horbinski CM, et al. Detection of histone H3 mutations in cerebrospinal fluid-derived tumor DNA
                   from children with diffuse midline glioma. Acta Neuropathol Commun 2017;5:28.
               35.  Panditharatna E, Kilburn LB, Aboian MS, Kambhampati M, Gordish-Dressman H, et al. Clinically relevant and minimally invasive tumor
                   surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res 2018;24:5850-9.
               36.  Wang Y, Springer S, Zhang M, McMahon KW, Kinde I, et al. Detection of tumor-derived DNA in cerebrospinal fluid of patients with
                   primary tumors of the brain and spinal cord. Proc Natl Acad Sci U S A 2015;112:9704-9.
               37.  Connolly ID, Li Y, Pan W, Johnson E, You L, et al. A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal
                   ependymoma. J Neurooncol 2017;135:29-36.
               38.  Kala R, Peek GW, Hardy TM, Tollefsbol TO. MicroRNAs: an emerging science in cancer epigenetics. J Clin Bioinforma 2013;3:6.
               39.  Morozova N, Zinovyev A, Nonne N, Pritchard LL, Gorban AN, et al. Kinetic signatures of microRNA modes of action. RNA
                   2012;18:1635-55.
               40.  Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are
                   microRNA targets. Cell 2005;120:15-20.
               41.  Bookland M, Tang-Schomer M, Gillan E, Kolmakova A. Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma
                   patients predicts mural nodule volume. Acta Neurochir (Wien) 2018;160:1571-81.
   66   67   68   69   70   71   72   73   74   75   76